secwatch.observer — SEC 8-K summary
======================================

Issuer:     Century Therapeutics, Inc. (IPSC)
CIK:        0001850119
Form:       8-K
Filed at:   2026-06-16T20:06:02+00:00
Accession:  0001104659-26-074577
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
LLM model:  deepseek-v4-flash:cloud@v2

Century Therapeutics CSO Chad Cowan moves to part-time with reduced salary
--------------------------------------------------------------------------

- Chad Cowan continues as CSO on part-time basis; salary cut to $296,150 annually.
- Eligible for pro-rated annual performance-based target bonus.
- Upon company termination or resignation, entitled only to accrued unpaid base salary.
- A&R Employment Agreement to be filed as exhibit to Q2 2026 10-Q.
- Agreement effective June 15, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850119/000110465926074577/0001104659-26-074577-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850119/000110465926074577/tm2617925d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-074577

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer